Drug Maker Tells Federal Circuit Ruling Invalidating Velcade Patent Was Error
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on Feb. 6 heard oral arguments in a dispute over the cancer-fighting prodrug Velcade, following findings in 2015 by a Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article